11Beta-hydroxysteroid dehydrogenase inhibition improves cognitive function in healthy elderly men and type 2 diabetics
about
Local amplification of glucocorticoids in the aging brain and impaired spatial memoryAppropriate function of 11beta-hydroxysteroid dehydrogenase type 1 in the endoplasmic reticulum lumen is dependent on its N-terminal region sharing similar topological determinants with 50-kDa esteraseThe role of glucocorticoid action in the pathophysiology of the Metabolic SyndromeBrain mineralocorticoid receptors in cognition and cardiovascular homeostasisPathway analysis reveals common pro-survival mechanisms of metyrapone and carbenoxolone after traumatic brain injuryTales of a Dirty Drug: Carbenoxolone, Gap Junctions, and SeizuresCompound library development guided by protein structure similarity clustering and natural product structureCharting biologically relevant chemical space: a structural classification of natural products (SCONP)Investigational anti-hyperglycemic agents: the future of type 2 diabetes therapy?11beta-hydroxysteroid dehydrogenase type 1 expression is increased in the aged mouse hippocampus and parietal cortex and causes memory impairments.Cerebrospinal fluid cortisol levels are higher in patients with delirium versus controls.Is 11beta-hydroxysteroid dehydrogenase type 1 a good therapeutic target for blockade of glucocorticoid actions?Morning cortisol levels and cognitive abilities in people with type 2 diabetes: the Edinburgh type 2 diabetes study.Mineralocorticoid receptor activation restores medial perforant path LTP in diabetic rats.A prospective study of diurnal cortisol and cognitive function in community-dwelling elderly people.Diabetes impairs hippocampal function through glucocorticoid-mediated effects on new and mature neuronsA pharmacological screening approach for discovery of neuroprotective compounds in ischemic strokeEvidence for expression of 11β-hydroxysteroid dehydrogenase type3 (HSD11B3/HSD11B1L) in neonatal pig testis.Bidirectional metabolic regulation of neurocognitive function.High postoperative serum cortisol level is associated with increased risk of cognitive dysfunction early after coronary artery bypass graft surgery: a prospective cohort study.11β-Hydroxysteroid dehydrogenase activity in the brain does not contribute to systemic interconversion of cortisol and cortisone in healthy men.11β-hydroxysteroid dehydrogenases and the brain: from zero to hero, a decade of progress.Inhibition of 11β-Hydroxysteroid Dehydrogenase Type II Suppresses Lung Carcinogenesis by Blocking Tumor COX-2 Expression as Well as the ERK and mTOR Signaling Pathways.Aging and stress: past hypotheses, present approaches and perspectivesIdentification of important chemical features of 11β-hydroxysteroid dehydrogenase type1 inhibitors: application of ligand based virtual screening and density functional theoryNeuroprotection provided by dietary restriction in rats is further enhanced by reducing glucocortocoids.Inhibition of 11beta-HSD1 as a novel treatment for the metabolic syndrome: do glucocorticoids play a role?Cognitive and Disease-Modifying Effects of 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibition in Male Tg2576 Mice, a Model of Alzheimer's Disease.Why is the management of glucocorticoid deficiency still controversial: a review of the literature.Do corticosteroids damage the brain?Mechanisms of disease: Selective inhibition of 11beta-hydroxysteroid dehydrogenase type 1 as a novel treatment for the metabolic syndrome.Tissue production of cortisol by 11beta-hydroxysteroid dehydrogenase type 1 and metabolic disease.11β-hydroxysteroid dehydrogenase inhibition as a new potential therapeutic target for alcohol abuseUnravelling the pathophysiology of delirium: a focus on the role of aberrant stress responsesThe relationship between type 2 diabetes and dementia.Voluntary exercise and caloric restriction enhance hippocampal dendritic spine density and BDNF levels in diabetic mice.11beta-hydroxysteroid dehydrogenase type 1 inhibitors: a review of recent patents.Selection and early clinical evaluation of the brain-penetrant 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitor UE2343 (Xanamem™)11β-hydroxysteroid dehydrogenases: intracellular gate-keepers of tissue glucocorticoid action.11β-hydroxysteroid dehydrogenase type 1, brain atrophy and cognitive decline.
P2860
Q21558420-DAC28EB8-A69D-4B2A-80F9-85592AAB8E0EQ24293608-31B82B4E-B129-4B6F-A2D3-12D95E2A32A7Q24803696-A323B679-211A-47A7-AC2F-15A8C3B13C91Q26995642-784DC5A3-D108-47A8-9570-C9711ACE9DACQ28484921-7CAFE79C-4897-4306-83B7-4D3EB0326CD5Q28972313-4FD16DF3-8C5C-4B94-B101-B8858E21C1F5Q30344285-2C971A1B-707A-4FE7-954E-68F88EFF4036Q30351855-13C7B93F-7F09-42F7-9B9D-53C185F7E8E2Q30426407-91D4CA1E-D07E-405B-8596-822AA0360E02Q30494882-A24D4328-DB3B-444A-B2D0-DA7B8F1EC7DBQ33533964-D518B792-EC80-4E12-9805-17D48EF36B31Q33693734-E257073A-7889-4996-A69B-0A37406497CEQ33751423-3A50997A-68B3-4AC2-90C3-003BC739461FQ33853599-F358ABC0-B8C9-4EBB-ADC9-6BA093DD3DA3Q33952157-9CECC607-C540-4E90-B941-34345583659CQ34083053-9D9D553F-A977-4E04-909F-9B3C1EC25EF4Q34853494-BCF23240-454C-4C46-A08B-82A2E80BA99FQ34861580-6AFAAF79-303C-49E0-AD01-2570E27DCA55Q34884241-E31BFB29-B741-4681-9C8F-119325E4128BQ35021806-944E6625-DDA9-4954-B5FF-EE21D0B57DCFQ35055047-89494126-0164-4310-9A73-05B723F43EE1Q35144168-8BD6EDB6-CB54-44F2-8A79-5D385F8A6ACBQ35641880-6B7BADCE-1C86-43E6-8344-5AF1CD52CEF0Q35806723-FBB48D44-A67A-494D-AA05-E4C0C6416B04Q35934104-2E5EC13D-C7CF-4517-B88F-83AB93AF7333Q36028337-A7FABEA6-DC7F-4018-89C8-1D9A45395F0FQ36266034-2323EBBE-77D4-4AF0-AC0C-BC81266D7EA3Q36305157-4342A730-5256-4A3F-9B47-0A82C0855917Q36305809-63F2E7C9-2DB8-4DE2-BC36-1888AA08D251Q36473162-25A2CDFB-4EBB-4F61-9FDB-9AD19725CF1EQ36575445-A58551FF-9A55-4962-9075-8C0D531D524AQ36674845-BB07F3B1-6DFF-4AC3-94EE-DCCDB3EADB78Q36915489-A379A7EA-7661-4EDD-A94B-5EFC38F1E448Q37245372-38B82465-387A-4086-AB7B-4D69C37D9DB6Q37333381-4185B00C-0AF9-43BF-96F9-B2295C2B8318Q37371569-0710FC35-005F-4949-A188-915832308C9CQ37489938-625C1962-8EFD-499D-A645-B61819664846Q37634771-8B6D15D0-E816-4B20-8249-E6563E4B61F2Q37655884-FF1E3F00-7612-4822-8380-02EEAB2B6652Q37687141-B565932B-4E12-4D15-8EDE-DCF746426882
P2860
11Beta-hydroxysteroid dehydrogenase inhibition improves cognitive function in healthy elderly men and type 2 diabetics
description
2004 nî lūn-bûn
@nan
2004 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
11Beta-hydroxysteroid dehydrog ...... derly men and type 2 diabetics
@ast
11Beta-hydroxysteroid dehydrog ...... derly men and type 2 diabetics
@en
11Beta-hydroxysteroid dehydrog ...... derly men and type 2 diabetics
@nl
type
label
11Beta-hydroxysteroid dehydrog ...... derly men and type 2 diabetics
@ast
11Beta-hydroxysteroid dehydrog ...... derly men and type 2 diabetics
@en
11Beta-hydroxysteroid dehydrog ...... derly men and type 2 diabetics
@nl
prefLabel
11Beta-hydroxysteroid dehydrog ...... derly men and type 2 diabetics
@ast
11Beta-hydroxysteroid dehydrog ...... derly men and type 2 diabetics
@en
11Beta-hydroxysteroid dehydrog ...... derly men and type 2 diabetics
@nl
P2093
P2860
P356
P1476
11Beta-hydroxysteroid dehydrog ...... derly men and type 2 diabetics
@en
P2093
Alasdair M J MacLullich
Brian R Walker
Ian J Deary
Jonathan R Seckl
Joyce L W Yau
June Noble
Thekkepat C Sandeep
P2860
P304
P356
10.1073/PNAS.0306996101
P407
P577
2004-04-27T00:00:00Z